Drug intelligence / Profile preview

isosorbide dinitrate

Development stage
Approved
Lead developer
Takeda
Modality
Small Molecules
Administration
Oral, Sublingual, Intravenous
01

Overview

Isosorbide dinitrate is a moderate to long-acting oral organic nitrate used for the relief and prophylactic management of angina pectoris and in the treatment of heart failure. It works by relaxing blood vessels (vasodilation), which decreases the workload on the heart and increases oxygen supply to cardiac tissue. The drug acts as a prodrug that is converted to nitric oxide (NO), which activates guanylate cyclase (specifically atrial natriuretic peptide receptor 1). This leads to increased cyclic guanosine monophosphate (cGMP) levels in smooth muscle cells and results in vasodilation. It is particularly useful for preventing angina attacks when taken regularly and has also been used with hydralazine for heart failure due to systolic dysfunction[1][2][3][5][8].

Brand names
IsochronIsordil TitradoseSorbitrateDilatrate-SRIsordilIsordil TembidsBidilDilatrateIsoket
Other names
isosorbide dinitrate spray
02

Targets

sGC (Soluble Guanylyl Cyclase)NPR1 (Natriuretic peptide receptor 1)

Beyond the preview

Go deeper on isosorbide dinitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isosorbide dinitrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call